Among General Practices, does a simple promotion strategy to encourage practitioners to screen parents for history of MMR vaccination whilst they attend the practice to have their young children vaccinated, result in an increase in the number of adults vaccinated against MMR, compared to existing ad-hoc practices?

GlaxoSmithKline pharmaceuticals0 个研究点目标入组 53 人开始时间: 2013年1月15日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Inclusion criteria for general practices (primary participants”): all general practices in South Eastern Sydney Local Health District with a vaccine account number (from the State Vaccine Centre)
•Inclusion criteria for participants indirectly included in the research (secondary participants”): Adults born in or after 1966 who attend the practice with a child for scheduled childhood vaccinations will be approached by the GP or practice nurse to participate.

•Exclusion criteria for general practices (primary participants”): general practices in South Eastern Sydney Local Health District that do not have a vaccine account number.
•Exclusion criteria for participants indirectly included in the research (secondary participants”):
•1. Adults born prior to 1966 who attend the practice with a child for routine childhood vaccinations.
•2. Adults unaccompanied by a child presenting for treatment or vaccination.
•3. Participants are not required to be immunised to be included in the study. Any participants who are pregnant, immunocompromised, symptomatic HIV positive, immunocompromised, allergic to any components in the vaccine will not be vaccinated, but a questionnaire will still be completed and the medical practice paid for its return. The participant’s information form will contain information on the contraindications for vaccination. The vaccine provider will also assess for contraindications as part of the NHMRC recommended routine pre vaccination assessment for all vaccinations (page 16, Australian Immunisation Handbook)
•4. Adults declining consent. Note, adult born on or after 1966 that decline participation in the study can still receive Priorix vaccine if they are not immune, have an uncertain or no vaccination history.

发起方